MetaCap

Bambusa Therapeutics Statistics

NASDAQ: BBTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

16.00+0.45 (+2.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Bambusa Therapeutics by the numbers

Bambusa Therapeutics has a market capitalization of $815.1 million based on 50.94M shares outstanding. With trailing EPS of $-1.73, Bambusa Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% below its 50-day average and 0.9% below its 200-day average.

Average daily trading volume is 359.41K shares, or about $5.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BBTX valuation vs. peer median

BBTX compared with the median of 8 peer companies
MetricBBTXPeer medianDifference
Market cap$815.08M$759.09M+7%
Avg. volume359.41K904.98K-60%

Peer median across 8 companies: ODTX, PRME, MGTX, IMTX, GLUE, AURA, SLDB, ATTO.

Valuation

Price and trading

Previous close
15.55
Open
15.46
Day range
15.21 – 16.69
52-week range
13.60 – 17.65
Beta
—
Volume
137.67K

Dividends and events

Additional statistics

Market Cap
815.08M
Eps
-1.73
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.65
Week52 Low
13.60
Avg Volume
359.41K
Shares Outstanding
50.94M
Ma50
16.15
Ma200
16.15
Pct From52w High
-9.35%
Pct From52w Low
17.65%

Related